TOMI advances toward NSF certification for life sciences

2 min read     Updated on 17 Jun 2026, 09:31 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

TOMI Environmental Solutions is advancing toward NSF certification for its SteraMist iHP technology to target pharmaceutical, biotech, and cleanroom markets. The company presented to the NSF Joint Committee on June 17, 2026, with strategic partner Total Clean Air to establish validation studies for biosafety cabinets.

powered bylight_fuzz_icon
42735767

*this image is generated using AI for illustrative purposes only.

TOMI Environmental Solutions, Inc. has announced a major step toward achieving NSF certification for its patented SteraMist ionized Hydrogen Peroxide (iHP) technology, a milestone that could accelerate adoption across pharmaceutical manufacturing, biotechnology, cleanroom, biosafety, and laboratory markets worldwide. The company, a global leader in disinfection and decontamination solutions, stated that NSF International is a global, independent organization that develops public health standards and certifications to protect food, water, consumer products, and the environment. This initiative targets some of the fastest-growing sectors of the global contamination-control industry, including pharmaceutical production facilities, vaccine manufacturing operations, cell and gene therapy laboratories, biomedical research institutions, biosafety cabinets, and high-containment environments.

Certification Process and Strategic Partnership

As part of the certification process, TOMI and its strategic partner, Total Clean Air (TCA), presented before the NSF Joint Committee on Biosafety Cabinets on June 17, 2026. The presentation is designed to establish the framework for formal validation studies to test the SteraMist iHP decontamination protocol across multiple types of biosafety cabinets (BSCs), which could ultimately lead to NSF certification of TOMI's SteraMist decontamination protocol. Management believes NSF certification would provide independent third-party validation of SteraMist's effectiveness, repeatability, and material compatibility, helping remove a significant barrier to adoption for highly regulated industries where validated decontamination procedures are critical.

Market Opportunity and Industry Trends

The global life sciences industry continues to invest heavily in contamination-control technologies driven by growth in biologics manufacturing, cell and gene therapy production, vaccine development, advanced research, and regulatory compliance requirements. TOMI believes SteraMist's rapid cycle times, broad-spectrum efficacy, and material compatibility position the technology to capitalize on these long-term industry trends. The company estimates that these markets represent billions of dollars in annual spending on contamination prevention, validation, and facility operations. Certification could help streamline purchasing decisions for facility operators, biosafety officers, pharmaceutical manufacturers, and equipment providers by providing an independent industry-recognized validation standard.

Leadership Commentary

"Achieving NSF certification has the potential to be a transformative milestone for TOMI," said Elissa (E.J.) Shane, COO of TOMI Environmental Solutions. "This process is about much more than biosafety cabinets. It is about positioning SteraMist for broader adoption across pharmaceutical manufacturing, biotechnology, research laboratories, cleanrooms, and other mission-critical environments where contamination control is essential." Shane added that the objective is to establish SteraMist as a trusted decontamination solution across the life sciences ecosystem, representing an important step toward expanding the addressable market, accelerating adoption, and creating new recurring revenue opportunities across multiple high-value industry verticals.

Key Metrics and Details

Metric Detail
Certification Body NSF International
Technology SteraMist ionized Hydrogen Peroxide (iHP)
Target Markets Pharmaceutical, biotechnology, cleanroom, biosafety, laboratory
Strategic Partner Total Clean Air (TCA)
Presentation Date June 17, 2026

What is the expected timeline for the completion of formal validation studies and the final granting of NSF certification?

How will TOMI leverage this certification to penetrate international markets with differing regulatory standards?

What specific revenue growth does management anticipate following the potential certification across the target pharmaceutical and biotechnology sectors?

like18
dislike
Must Read Next

Earnings

Corporate Actions

Stocks